| Literature DB >> 27026949 |
M T Bahreyni Toossi1, F Khorshidi1, M Ghorbani1, N Mohamadian1, D Davenport2.
Abstract
BACKGROUND: EBT and EBT3 radioChromic films have been used in radiotherapy dosimetry for years.Entities:
Keywords: EBT; EBT3; Parotid cancer; RadioChromic film; Radiotherapy
Year: 2016 PMID: 27026949 PMCID: PMC4795323
Source DB: PubMed Journal: J Biomed Phys Eng ISSN: 2251-7200
Figure 1Schematic structure of EBT and EBT3 RadioChromic films
Detailed information on RAO and RPO fields in treatment of parotid cancer.
|
|
| |
|---|---|---|
|
| 98.0 | 98.0 |
|
| 6.0×8.4 | 6.0×8.4 |
|
| 10.0 | 350.0 |
|
| 325 | 235.0 |
|
| 3RW30 | 4RW30 |
|
| X2 | X1 |
|
| 0.516 | 0.516 |
Figure 2RANDO phantom and the position of the marker used in skin dosimetry of parotid cancer
Figure 3Schematic positions of the film pieces in the RAO and RPO fields
NOD obtained from calibration process for EBT and EBT3 radioChromic films and the percentage dose differences (%).
|
|
|
| |
|---|---|---|---|
|
|
| ||
| 0.2 | 0.0241 | 0.0233 | 2.92 |
| 0.5 | 0.0592 | 0.0382 | 35.47 |
| 0.75 | 0.0930 | 0.0798 | 14.19 |
| 1.0 | 0.1127 | 0.1019 | 9.58 |
| 1.25 | 0.1355 | 0.1232 | 9.08 |
| 1.5 | 0.1540 | 0.1418 | 7.92 |
| 1.75 | 0.1702 | 0.1582 | 7.05 |
| 2.5 | 0.2204 | 0.2024 | 8.17 |
| 3.5 | 0.2743 | 0.2492 | 9.15 |
| 5.0 | 0.3275 | 0.3097 | 5.44 |
Figure 4Calibration curve for EBT and EBT3 films
NOD obtained from in-phantom measurements for EBT and EBT3 radioChromic films and the percentage dose differences (%)
|
|
|
| |
|---|---|---|---|
|
|
| ||
| 0 | 0.0317 | 0.0311 | 1.89 |
| 0.1 | 0.0861 | 0.0757 | 12.08 |
| 1.5 | 0.1475 | 0.1328 | 9.97 |
| 2.0 | 0.1442 | 0.1339 | 7.14 |
| 4.0 | 0.1354 | 0.1236 | 8.71 |
| 10.0 | 0.1064 | 0.0985 | 7.42 |
Dose (Gy) obtained from EBT and EBT3 radioChromic films and Semiflex ionization chamber and the percentage dose differences (%)
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 0 | 0.3159 | 0.2768 | 0.61 | 12.38 | -93.10 | -120.38 |
| 0.1 | 0.6856 | 0.7030 | 0.80 | -2.54 | -16.69 | -13.80 |
| 1.5 | 1.3909 | 1.3956 | 1.46 | -0.34 | -4.97 | -0.05 |
| 2.0 | 1.3460 | 1.4108 | 1.45 | -4.81 | -7.73 | -2.78 |
| 4.0 | 1.2298 | 1.2715 | 1.33 | -3.39 | -8.15 | -4.60 |
| 10.0 | 0.8873 | 0.9581 | 1.00 | -7.98 | -12.70 | -4.37 |
NOD obtained from skin dosimetry in RAO and RPO of parotid cancer radiotherapy for EBT and EBT3 radioChromic films and the percentage dose differences (%). The film positions are based on Figure 3.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
| |||
| 1 | 0.0352 | 0.0285 | 19.04 | 0.0491 | 0.0367 | 25.25 |
| 2 | 0.0390 | 0.0329 | 15.64 | 0.0415 | 0.0329 | 20.72 |
| 3 | 0.0434 | 0.0333 | 23.27 | 0.0437 | 0.0333 | 23.80 |
| 4 | 0.0440 | 0.0313 | 28.86 | 0.0431 | 0.0335 | 22.27 |
| 5 | 0.0433 | 0.0345 | 20.32 | 0.0495 | 0.0365 | 26.26 |
Dose (Gy) obtained from skin dosimetry in RAO and RPO of parotid cancer radiotherapy for EBT and EBT3 radioChromic films and the percentage dose differences (%)
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
| |||
| 1 | 0.3299 | 0.2546 | 22.83 | 0.4026 | 0.3254 | 19.18 |
| 2 | 0.3478 | 0.2922 | 15.99 | 0.3606 | 0.2922 | 18.97 |
| 3 | 0.3706 | 0.2957 | 20.21 | 0.3722 | 0.2957 | 20.55 |
| 4 | 0.3738 | 0.2785 | 25.49 | 0.3690 | 0.2974 | 19.40 |
| 5 | 0.3701 | 0.3061 | 17.29 | 0.4055 | 0.3236 | 20.20 |